Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Analysis of β-catenin alterations in colon tumors: a novel exon 3 mutation.

Akisik E, Buğra D, Yamaner S, Dalay N.

Tumour Biol. 2011 Feb;32(1):71-6. doi: 10.1007/s13277-010-0099-4. Epub 2010 Aug 18.

PMID:
20717765
2.
3.

Functional correlates of mutations in beta-catenin exon 3 phosphorylation sites.

Provost E, Yamamoto Y, Lizardi I, Stern J, D'Aquila TG, Gaynor RB, Rimm DL.

J Biol Chem. 2003 Aug 22;278(34):31781-9. Epub 2003 Jun 10.

4.

beta-Catenin mutation is selected during malignant transformation in colon carcinogenesis.

Yamada Y, Oyama T, Hirose Y, Hara A, Sugie S, Yoshida K, Yoshimi N, Mori H.

Carcinogenesis. 2003 Jan;24(1):91-7.

PMID:
12538353
5.
7.

Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.

Hagen T, Vidal-Puig A.

Biochem Biophys Res Commun. 2002 Jun 7;294(2):324-8.

PMID:
12051714
8.

Predominant mutation of codon 41 of the beta-catenin proto-oncogene in rat colon tumors induced by 1,2-dimethylhydrazine using a complete carcinogenic protocol.

Koesters R, Hans MA, Benner A, Prosst R, Boehm J, Gahlen J, Doeberitz MK.

Carcinogenesis. 2001 Nov;22(11):1885-90.

PMID:
11698353
9.

Phosphorylation and ubiquitination of oncogenic mutants of beta-catenin containing substitutions at Asp32.

Al-Fageeh M, Li Q, Dashwood WM, Myzak MC, Dashwood RH.

Oncogene. 2004 Jun 17;23(28):4839-46.

10.

Evidence of a stabilizing mutation of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas.

Starker LF, Fonseca AL, Akerström G, Björklund P, Westin G, Carling T.

Endocrine. 2012 Dec;42(3):612-5. doi: 10.1007/s12020-012-9690-3. Epub 2012 May 11. Erratum in: Endocrine. 2012 Dec;42(3):769. Fonseca, Annabelle [corrected to Fonseca, Annabelle L].

PMID:
22576020
11.

Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane.

Takahashi M, Nakatsugi S, Sugimura T, Wakabayashi K.

Carcinogenesis. 2000 Jun;21(6):1117-20.

PMID:
10836998
12.

Stimulation of protein kinase C-alpha suppresses colon cancer cell proliferation by down-regulation of beta-catenin.

Gwak J, Jung SJ, Kang DI, Kim EY, Kim DE, Chung YH, Shin JG, Oh S.

J Cell Mol Med. 2009 Aug;13(8B):2171-80. doi: 10.1111/j.1582-4934.2009.00683.x.

13.

Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.

Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagneré AM, René-Corail F, Jullian E, Gicquel C, Bertagna X, Vacher-Lavenu MC, Perret C, Bertherat J.

Cancer Res. 2005 Sep 1;65(17):7622-7.

14.
15.

beta-Catenin mutation in rat colon tumors initiated by 1,2-dimethylhydrazine and 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol.

Blum CA, Xu M, Orner GA, Fong AT, Bailey GS, Stoner GD, Horio DT, Dashwood RH.

Carcinogenesis. 2001 Feb;22(2):315-20. Erratum in: Carcinogenesis 2001 Apr;22(4):685.

PMID:
11181454
16.
17.

Expression and mutation pattern of β-catenin and adenomatous polyposis coli in colorectal cancer patients.

Abdelmaksoud-Damak R, Miladi-Abdennadher I, Triki M, Khabir A, Charfi S, Ayadi L, Frikha M, Sellami-Boudawara T, Mokdad-Gargouri R.

Arch Med Res. 2015 Jan;46(1):54-62. doi: 10.1016/j.arcmed.2015.01.001. Epub 2015 Feb 3.

PMID:
25660336
18.

Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway.

Mirabelli-Primdahl L, Gryfe R, Kim H, Millar A, Luceri C, Dale D, Holowaty E, Bapat B, Gallinger S, Redston M.

Cancer Res. 1999 Jul 15;59(14):3346-51.

19.

Diverse Basis of β-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis.

Okabe H, Kinoshita H, Imai K, Nakagawa S, Higashi T, Arima K, Uchiyama H, Ikegami T, Harimoto N, Itoh S, Ishiko T, Yoshizumi T, Beppu T, Monga SP, Baba H, Maehara Y.

PLoS One. 2016 Apr 21;11(4):e0152695. doi: 10.1371/journal.pone.0152695. eCollection 2016.

20.

Frequent beta-catenin overexpression without exon 3 mutation in cutaneous lymphomas.

Bellei B, Pacchiarotti A, Perez M, Faraggiana T.

Mod Pathol. 2004 Oct;17(10):1275-81.

Supplemental Content

Support Center